EMJ Oncology 9 [Supplement 5] . 2021

In this issue

In this supplement to EMJ Oncology, two internationally renowned experts, Andres J. Muñoz Martin and Annie Young, explored risk assessment models for cancer-related venous thromboembolism (VTE), as well as the use of direct oral anticoagulants (DOACs) for the treatment of cancer-associated thrombosis.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.